Clinical Trials Browser

Phase 1/2 × midostaurin × Lymphoid × Clear all

NCT00866281 2015-12-22

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Phase 1/2 Terminated

22 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma